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Abstract
The authors describe a case of a 31-year-old female with tuberous sclerosis, a genetic, rare, variably
expressed disease. Clinical symptoms were chest pain, and progressive dyspnea. Computed
tomography scan of the chest showed bilateral, diffuse, small thin-walled cysts scattered
throughout the lungs characteristic for pulmonary lymphangioleiomyomatosis. Computed
tomography scan of the abdomen revealed enlarged, heterogeneous kidneys, with low density
tumors corresponding to angiomyolipomas. Pulmonary lymphangioleiomyomatosis and bilateral
renal angiomyolipomas are some presentations of tuberous sclerosis and the coexistence of both
conditions may cause devastating morbidity and mortality.
Introduction
Tuberous sclerosis (TS) is an autosomal dominant disor-
der characterized by the formation of hamartomatous
lesions in multiple organs, with a birth incidence of
around one in 10,000 [1]. However, with more sensitive
screening the prevalence may be as high as one in 6,000
[2,3]. The disease results from mutations in one of two
genes,  TSC1  (encoding hamartin) or TSC2  (encoding
tuberin), which have an important role in the regulation
of cell proliferation and differentiation [4]. Facial angiofi-
bromas, renal angiomyolipomas, and pulmonary lym-
phangiomyomatosis (LAM) are some of the major
features of this disease [4]. Diagnosis is usually estab-
lished on the basis of physical examination, radiological
findings or both, and the presentation of the disease varies
substantially. We report a case of a female patient with TS
presenting with pulmonary lymphangiomyomatosis and
bilateral renal angiomyolipomas.
Case presentation
A 31-year-old Caucasian Brazilian woman was admitted
to the hospital with a 6-month history of chest pain and
progressive dyspnea on exertion. She had angiofibromas
on the malar regions of the face, which were present since
her childhood. During her pregnancy, 11 years ago, she
was diagnosed with polycystic kidney disease associated
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with tuberous sclerosis. She had repetitive urinary tract
infections, which resulted in progressive loss of renal
function. Both her grandfather and child had polycystic
kidneys, and her son also presented seizures. The patient
also had a history of hemorrhoidal disease causing inter-
mittent bleeding.
On examination, the patient appeared pale, and her vital
signs included a blood pressure of 120/80 mmHg and a
heart rate of 110 bpm. Auscultation revealed the presence
of fine crackles in both lungs, and a loud systolic heart
murmur was heard on the precordium. Her abdomen was
tense and painful to palpation, but there were no signs of
peritoneal irritation. There was a palpable mass occupying
the upper abdomen and both flanks; Traube's space was
obliterated. Laboratory evaluation revealed a red blood
cell (RBC) count of 2.81 × 106/mm3, hemoglobin level of
9.0 g/dL, hematocrit of 27% and platelet count of 130 ×
103/mm3. Her WBC count was normal. Serum creatinine
was 3.3 mg/dL; urea, 87 mg/dL; glucose, 85 mg/dL;
sodium, 135 mEq/L; potassium, 4.2 mEq/L; uric acid 4.5
mg/dL; albumin, 2.8 g/dL; calcium, 7.9 mg/dL; phospho-
rus, 5.2 mg/dL; and magnesium, 2.4 mg/dL.
Chest computed tomography (CT) revealed cystic forma-
tions throughout the lungs, consistent with lymphangio-
leiomyomatosis (Figure 1), and the presence of a
pericardial effusion. The echocardiogram showed a small
pericardial effusion, and moderate left ventricular hyper-
trophy, and a normal systolic function. An abdominal CT
scan demonstrated enlarged, heterogeneous kidneys, with
multiple fat-density formations (negative densities, rang-
ing from -15 to -148 Hounsfield units), which corre-
sponded to angiomyolipomas (Figure 2). Pulmonary
function tests showed a severe obstructive pulmonary dis-
order with reduced forced vital capacity, and a positive
response to bronchodilator. She started treatment with
medroxyprogesterone, and her respiratory status
remained stable. An echocardiogram performed three
years later revealed worsening of cardiac condition,
enlargement of right cavities and left atrium, and thicken-
ing of the aortic valve leaflets; systolic function was pre-
served. Follow-up CT scans did not show significant
changes.
Discussion
The benign, non-invasive lesions of tuberous sclerosis can
appear in any organ like the brain, heart, skin, eyes, kid-
ney, lung, and liver. Therefore, TS has a wide clinical spec-
trum. The diagnosis of definitive TS is based on specific
clinical features and requires the presence of two major
criteria, or one major and two minor [3]. Pulmonary lym-
phangioleiomyomatosis, renal angiomyolipoma and
facial angiofibroma are some of the major clinical fea-
tures.
The most frequent cause of death in patients with TS is
renal complication [3,5]. Multifocal, bilateral angiomyol-
ipomas are found in about 70-90% of adult patients [3],
and the prevalence increases with age, being less frequent
in children [3,4]. These lesions are more often prevalent
in women, suggesting a hormonal component to the
tumor growth [6]. The angiomyolipomas are composed of
varying amounts of mature adipose tissue, smooth mus-
cle, and abnormal blood vessels [3,6]. The demonstration
of intratumoral fat with negative attenuation values at CT
is virtually pathognomonic of angiomyolipoma. Thin-sec-
tion unenhanced CT is essential to visualize the fat con-
tent of angiomyolipomas [7]. Progressive enlargement of
tumors and hemorrhage into the lesion can result in flank
pain, a palpable tender mass and gross or microscopic
hematuria, and interfere with renal function [6]. Tumors
larger than 4 cm in diameter have a greater risk of sponta-
neous or traumatic rupture resulting in hemorrhagic com-
plications [6], which is the most common cause of death
in patients with TS [8]. Some patients with TS carry a con-
A and B. High-resolution CT of the chest at the level of the  upper (A) and lower lobes (B) shows well defined thin-walled  cysts randomly scattered throughout both lungs Figure 1
A and B. High-resolution CT of the chest at the level 
of the upper (A) and lower lobes (B) shows well 
defined thin-walled cysts randomly scattered 
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tiguous germline deletion that affects both the TSC2 gene
and the adjacent gene, polycystic kidney disease type 1
(PKD1), resulting in a polycystic kidney phenotype that
leads to early renal insufficiency [3,4]. In our patient, the
family history indicates that she inherited a germline
mutation in the TSC2  gene. Renal cell carcinoma can
occur in approximately 2-3% of adults with TS [3].
Pulmonary LAM is a rare progressive disease that predom-
inantly affects women of childbearing age. Estrogen is
thought to play a role in disease progression since it does
not present prior to menarche and only rarely after meno-
pause [9], and is exceptionally rare in men [1,3,8]. LAM
probably affects 1-3% of patients with tuberous sclerosis
[3,5]. Although some articles report the occurrence of
LAM in 1 to 3% of the patients with TS [3,5], it seems that
this incidence is much higher. Recent articles [10-12]
report an incidence ranging from 26 to 34%. It is charac-
terized by alveolar smooth-muscle proliferation leading
to air trapping, pulmonary hemorrhage and lymphatic
extravasation, and cystic destruction of the normal lung
parenchyma [3]. Some of the manifestations are shortness
of breath, coughing, chest pain, pneumothorax, chylous
pleural effusions, hemoptysis, and eventually respiratory
failure, but asymptomatic cases may occur [1,3,4]. Pulmo-
nary function tests can show an obstructive or restrictive
pattern [1]. Classical CT findings (diffuse, homogeneous,
small thin-walled cysts) and compatible clinical history
can be highly suggestive of LAM [5]. It is extremely diffi-
cult to treat, and the long-term prognosis is poor with the
average duration of survival from the time of diagnosis
near to 10 years [1]. Treatment consists of supportive
management; hormonal therapy has been tried but with-
out consistent success [1,9]. Sirolimus (rapamycin) is
being explored as another potential treatment, but addi-
tional trials will be needed to assess efficacy and potential
side effects [11,13].
Renal angiomyolipomas are present in 93% of patients
with tuberous-sclerosis-associated pulmonary lymphangi-
omyomatosis [3]. It is important to recognize LAM before
renal surgery for angiomyolipoma because of the risk of
spontaneous pneumothorax or other perioperative pul-
monary complication [5,8]. Pneumothoraces ultimately
occur in approximately 60 to 70% of patients with LAM,
and the rate of recurrence is > 70%, the highest among all
chronic lung diseases [11].
Finally, it is very important to understand that a patient
with TS requires a multidisciplinary clinical staff to receive
a complete evaluation of the multisystem complications.
In patients with lymphangiomyomatosis, annual pulmo-
nary-function testing may be useful to monitor lung func-
tion and provide a measure of disease progression [4]. The
monitoring of angiomyolipomas growth, by ultrasonog-
raphy, CT, or magnetic resonance, is an essential issue in
the management of TS [4].
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A and B. CT of the upper abdominal region demonstrates  bilateral giant renal masses consisting predominantly of fat  tissue Figure 2
A and B. CT of the upper abdominal region demon-
strates bilateral giant renal masses consisting pre-
dominantly of fat tissue. The density measurement of the 
hypodense content ranged from -15 to -148 Ho unsfield 
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